Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Becomes the first rehab & recovery center in east India to earn NABH accreditation
The partnership marks a significant milestone in integrating digital health education into medical curricula
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Subscribe To Our Newsletter & Stay Updated